A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015)

NCT01774773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Group A: E5501 5mg, then 20mg, then 40 mg, then 5mg
DRUG: Group B: E5501 20mg, then 40mg, then 5 mg, then 5mg
DRUG: Group C: E5501 40mg, then 5mg, then 20 mg, then 5mg

Sponsor

Eisai Co., Ltd.